Discover
INAB
IN8bio, Inc.
1.42
2 x 1.04
2 x 1.81
bid
ask
+
0.01
0.71%
2 @ 04:00 PM
1.41 -0.01 (0.70%)
| Ytd | -39.32% | |
| 1y | -31.40% |
1.40
day range
1.45
1.17
52 week range
2.73
| Open | 1.42 | Prev Close | 1.41 | Low | 1.40 | High | 1.45 | Mkt Cap | 13.62M |
| Vol | 16.86K | Avg Vol | 57.55K | EPS | -2.54 | P/E | N/A | Forward P/E | -0.80 |
| Beta | -0.07 | Short Ratio | 0.51 | Inst. Own | 46.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.53 | 200-d Avg | 1.80 | 1yr Est | 4.75 |
| Income Statement | |||
| Operating Expenses | 5.27M | ||
| Research and Development Expense | 2.61M | ||
| Selling, General and Administrative Expense | 2.65M | ||
| Operating Income | -5.27M | ||
| Net Income | -5.09M | ||
| Net Income Common Stock | -5.09M | ||
| Net Income Common Stock (USD) | -5.09M | ||
| Consolidated Income | -5.09M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -5.09M | ||
| Earning Before Interest & Taxes (USD) | -5.09M | ||
| Weighted Average Shares | 19.47M | ||
| Weighted Average Shares Diluted | 19.47M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.94M | ||
| Cash and Equivalents (USD) | 21.94M | ||
| Investments | 220.00K | ||
| Investments Non-Current | 220.00K | ||
| Current Assets | 22.66M | ||
| Property, Plant & Equipment Net | 3.25M | ||
| Total Assets | 26.27M | ||
| Debt Current | 1.03M | ||
| Total Debt | 2.35M | ||
| Current Liabilities | 2.16M | ||
| Debt Non-Current | 1.33M | ||
| Total Liabilities | 3.48M | ||
| Accumulated Retained Earnings (Deficit) | -146.19M | ||
| Shareholders Equity | 22.78M | ||
| Shareholders Equity (USD) | 22.78M | ||
| Assets Non-Current | 3.60M | ||
| Total Debt (USD) | 2.35M | ||
| Liabilities Non-Current | 1.33M | ||
| Trade and Non-Trade Payables | 449.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 500.00K | ||
| Net Cash Flow from Financing | -195.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.15M | ||
| Capital Expenditure | -9.00K | ||
| Issuance (Purchase) of Equity Shares | -88.00K | ||
| Issuance (Repayment) of Debt Securities | -107.00K | ||
| Net Cash Flow from Investing | -9.00K | ||
| Net Cash Flow from Operations | -4.95M | ||
| Share Based Compensation | 401.00K | ||